4/A: Quaker Chemical VP Corrects RSU Grant to 445 Units

Kevin K. Meagher, VP of R&D at Quaker Chemical, amended a previous filing to reflect a higher grant of 445 Restricted Stock Units.

Summary

• Kevin K. Meagher, VP, R&D Advanced Solutions at Quaker Chemical Corp (KWR), filed an amendment (Form 4/A) to a previous Statement of Changes in Beneficial Ownership.
• The amendment corrects an error in the original Form 4 filed on March 17, 2026.
• The original filing erroneously reported 297 time-based Restricted Stock Units (RSUs) acquired under the Company's Long-Term Performance Incentive Plan.
• The correct number of RSUs acquired on March 15, 2026, was 445.
• RSUs represent a contingent right to receive one share of KWR common stock.
• Dividend Equivalent Rights accrue when and as dividends are paid on KWR common stock.
• The RSUs will vest in three annual installments beginning on March 15, 2027.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive clarification of executive compensation, increasing the reported equity grant for the VP, and demonstrating the company's commitment to accurate disclosure.

Positives

• The reporting person, Kevin K. Meagher, received a higher number of Restricted Stock Units (445) than initially reported (297), increasing his potential future equity stake.
• The company demonstrated transparency by promptly correcting the erroneous filing.

Negatives

• An initial error was made in reporting the number of Restricted Stock Units, requiring an amendment.

Future Outlook

The 445 Restricted Stock Units granted to Kevin K. Meagher are scheduled to vest in three annual installments, commencing on March 15, 2027.

Management Comments

• The reporting person, Kevin K. Meagher, through his attorney-in-fact, Victoria K. Gehris, confirmed the correction of the RSU grant amount.

Industry Context

StockSavvy.ai notes that this filing represents a routine administrative correction of an executive equity grant, which is a standard component of compensation packages across various industries. Such amendments are common to ensure accuracy in public disclosures of insider holdings.

Stakeholder Impact

• Shareholders: Provides accurate disclosure regarding executive equity compensation, ensuring transparency in insider holdings.
• Executive (Kevin K. Meagher): Benefits from a corrected, higher grant of Restricted Stock Units, increasing his potential future ownership in the company.

Next Steps

• The Restricted Stock Units will vest in three annual installments beginning on March 15, 2027.

Key Dates

Recommendation

This filing is an administrative correction of an executive's RSU grant and does not contain information significant enough to alter an investment thesis for Quaker Chemical Corp. It provides clarity on executive compensation but does not impact the company's operational or financial performance.

Keywords

Quaker Chemical, KWR, SEC Form 4/A, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Equity Grant, Amendment